Skip to main content
Log in

Workshop on Bioanalytical Methods Validation for Macromolecules: Summary Report

  • Conference Report
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. V. P. Shah, K. K. Midah, S. Dighe, I. J. McGilveray, J. P. Skelley, A. Yacobi, T. Layloff, C. T. Viswanathan, C. E. Cook, R. D. McDowall, K. A. Pittman, and S. Spector. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm. Res. 9:588–592 (1992).

    Google Scholar 

  2. V. P. Shah, K. K. Midha, J. W. A. Findlay, H. M. Hill, J. D. Hulse, J. McGilveray, G. McKay, K. J. Miller, R. N. Patnaik, M. L. Powell, A. Tonelli, C. T. Viswanathan, and A. Yacobi. Bioanalytical methods validation—a revisit with a decade of progress. Pharm. Res. 17:1551–1557 (2000).

    Google Scholar 

  3. J. W. Findlay, W. C. Smith, J. W. Lee, G. D. Nordblom, I. Das, B. S. DeSilva, M. N. Khan, and R. R. Bowsher. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J. Pharm. Biomed. Anal. 21:1249–1273 (2000).

    Google Scholar 

  4. H. T. Karnes, G. Shiu, and V. P. Shah. Validation of bioanalytical methods. Pharm. Res. 8:421–426 (1991).

    Google Scholar 

  5. J. Neter, W. Wasserman, and M. H. Kutner. Aptness of model and remedial measures. In Applied Linear Regression Models. Richard D. Irwin, Inc., Homewood, Illinois, 1983. pp. 109–146.

    Google Scholar 

  6. M. A. Takacs, S. J. Jacobs, R. M. Bordens, and S. J. Swanson. Detection and characterization of antibodies to PEG-IFN-alpha2b using surface plasmon resonance. J. Interferon Cytokine Res. 19:781–789 (1999).

    Google Scholar 

  7. [FDA] Food and Drug Administration. Center for Biologics Evaluation and Research, Meeting of the Biological Response Modifiers Advisory Committee. Thursday, July 15, 1999.

  8. G. J. Downing. Biomarkers and surrogate endpoints: clinical research and applications. Elsevier Science, Amsterdam, The Netherlands 2000.

    Google Scholar 

  9. M. Wadhwa and R. Thorpe. Standardization and calibration of cytokine immunoassays: meeting report and recommendations. Cytokine 9:791–793 (1997).

    Google Scholar 

  10. A. Ledur, C. Fitting, B. David, C. Hamberger, and J. M. Cavaillon. Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards. J. Immunol. Methods 186:171–179 (1995).

    Google Scholar 

  11. R. O. Kringle. An assessment of the 4-6-20 rule for acceptance of analytical runs in bioavailability, bioequivalence, and pharmacokinetic studies. Pharm. Res. 11:556–560 (1994).

    Google Scholar 

  12. C. Hartmann, D. L. Massart, and R. D. McDowall. An analysis of the Washington Conference Report on bioanalytical method validation. J. Pharm. Biomed. Anal. 12:1337–13343 (1994).

    Google Scholar 

  13. R. O. Kringle and R. C. Khan-Malek. A statistical assessment of the recommendations from a conference on analytical methods validation in bioavailability, bioequivalence, and pharmacokinetic studies. Proceedings of the Biopharmaceutical Section of the American Statistical Association, Alexandria, VA, August 13–18, 1994. 510–514.

  14. P. Hubert, P. Chiap, J. Crommen, B. Boulanger, E. Chapuzet, N. Mercier, S. Bervoas-Martin, P. Chevalier, D. Grandjean, P. Lagorce, M. Lallier, M. C. Laparra, M. Laurentie, and J. C. Nivet. The SFSTP guide on the validation of chromatographic methods for drug analysis: from the Washington Conference to the laboratory. Anal. Chim. Acta 391:135–148 (1999).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miller, K.J., Bowsher, R.R., Celniker, A. et al. Workshop on Bioanalytical Methods Validation for Macromolecules: Summary Report. Pharm Res 18, 1373–1383 (2001). https://doi.org/10.1023/A:1013062600566

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013062600566

Navigation